Randomized phase III trial: Topotecan vs. topotecan/etoposide vs topotecan/gemcitabine as second-line treatment for patients with relapsed ovarian cancer.

被引：0
|
作者：
Sehouli, J
Sommer, H
Klare, P
Stauch, M
Zeimet, A
Paulenz, A
Renziehausen, K
Keil, E
Lichtenegger, W
Oskay-Ozcelik, G
机构：
[1] Med Univ, Charite, Berlin, Germany
[2] NE German Soc Gynecol Oncol, Berlin, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5139
引用
收藏
页码：483S / 483S
页数：1
相关论文
共 50 条
  • [31] Independent radiological review of a phase III study of topotecan versus paclitaxel as second-line therapy in advanced epithelial ovarian cancer
    Gwyther, SJ
    Gore, M
    Huinink, WT
    Fields, SZ
    Hudson, I
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 533 - 533
  • [32] Phase II study of weekly topotecan in patients with relapsed platinum-sensitive ovarian or peritoneal cancer.
    Morris, RT
    Alvarez, RD
    Malone, J
    Bryant, C
    Andrews, SJ
    Kilgore, L
    Phibbs, GD
    Heilbrun, L
    Munkarah, AR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 468S - 468S
  • [33] The combination of cisplatin and topotecan as a second-line treatment for patients with advanced/recurrent uterine cervix cancer
    Moon, Ji Young
    Song, Ik-Chan
    Ko, Young Bok
    Lee, Hyo Jin
    MEDICINE, 2018, 97 (14)
  • [34] A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancer
    Gore, M
    Oza, A
    Rustin, G
    Malfetano, J
    Calvert, H
    Clarke-Pearson, D
    Carmichael, J
    Ross, G
    Beckman, RA
    Fields, SZ
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (01) : 57 - 63
  • [35] Efficacy of ATR inhibitor berzosertib plus topotecan or topotecan alone in patients with relapsed small cell lung cancer: A randomized clinical trial
    Takahashi, Nobuyuki
    Hao, Zhonglin
    Villaruz, Liza C.
    Zhang, Jun
    Ruiz, Jimmy
    Petty, W. Jeffrey
    Mamdani, Hirva
    Riess, Jonathan W.
    Nieva, Jorge
    Pachecho, Jose M.
    Fuld, Alexander D.
    Shum, Elaine
    Chauhan, Aman
    Nichols, Samantha
    Shimellis, Hirity
    McGlone, Jessie
    Sciuto, Linda
    Pinkiert, Danielle
    Graham, Chante
    Shelat, Meenakshi
    Kattappuram, Robbie
    Abel, Melissa
    Schroeder, Brett
    Upadhyay, Deep
    Krishnamurthy, Manan
    Sharma, Ajit Kumar
    Kumar, Rajesh
    Malin, Justin
    Schultz, Christopher W.
    Goya, Shubhank
    Redon, Christophe E.
    Pommier, Yves
    Aladjem, Mirit I.
    Gore, Steven D.
    Steinberg, Seth M.
    Vilimas, Rasa
    Desai, Parth
    Thomas, Anish
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [36] Combination of weekly topotecan and gemcitabine as a salvage treatment in patients with recurrent ovarian cancer: a phase I study
    Syrios, John
    Kouroussis, Charalambos
    Kotsakis, Athanasios
    Kentepozidis, Nikolaos
    Kontopodis, Emmanouil
    Kalbakis, Kostas
    Vardakis, Nikolaos
    Hatzidaki, Dora
    Polyzos, Aris
    Georgoulias, Vassilis
    MINERVA GINECOLOGICA, 2019, 71 (03): : 182 - 190
  • [37] Phase II Trial of metronomic Temozolomide and Topotecan in patients with relapsed and/or refractory Small Cell Lung Cancer.
    Bhattacharyya, Gouri Shankar
    Parikh, Purvish M.
    Biswas, Ghanashyam
    Bondarde, Shailesh A.
    Malhotra, Hemant
    Vora, Amish
    Govindbabu, K.
    Ranade, Anantbhushan A. B.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S743 - S743
  • [38] Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan
    Mau-Sorensen, Morten
    Gerner-Rasmussen, Jonas
    Hansen, Olfred
    Holm, Bente
    Nyhus, Christa Haugaard
    McCulloch, Tine
    Nielsen, Henrik Anker
    Wedervang, Kim
    Rytter, Carsten
    Jeppesen, Nina
    Langer, Seppo W.
    Danish Oncological Lung Canc Grp
    ACTA ONCOLOGICA, 2023, 62 (12) : 1979 - 1982
  • [39] Phase II trial with Topotecan and Ifosfamide combination in the treatment of recurrent ovarian cancer
    Latorre, A.
    Decio, R.
    Calabrese, R.
    Giampaglia, M.
    Spada, M.
    Misino, A.
    Cova, D.
    Baruffi, S.
    Lombardi, F.
    Lorusso, V.
    ANNALS OF ONCOLOGY, 2005, 16 : 154 - 154
  • [40] PHASE II TRIAL WITH TOPOTECAN AND IFOSFAMIDE COMBINATION IN THE TREATMENT OF RECURRENT OVARIAN CANCER
    Latorre, A.
    Decio, R.
    Calabrese, R.
    Giampaglia, M.
    Spada, M.
    Lorusso, V.
    ANNALS OF ONCOLOGY, 2004, 15 : 93 - 93
12345